{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:41:17Z","timestamp":1784122877396,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003655","name":"National Institute of Food and Drug Safety Evaluation","doi-asserted-by":"publisher","award":["MFDS-7036-306"],"award-info":[{"award-number":["MFDS-7036-306"]}],"id":[{"id":"10.13039\/501100003655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003655","name":"National Institute of Food and Drug Safety Evaluation","doi-asserted-by":"publisher","award":["19181MFDS401"],"award-info":[{"award-number":["19181MFDS401"]}],"id":[{"id":"10.13039\/501100003655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003655","name":"National Institute of Food and Drug Safety Evaluation","doi-asserted-by":"publisher","award":["19181MFDS402"],"award-info":[{"award-number":["19181MFDS402"]}],"id":[{"id":"10.13039\/501100003655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00213-021-05840-9","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T09:02:46Z","timestamp":1617440566000},"page":"2155-2165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of the abuse potential of methamnetamine in rodents: a behavioral pharmacology study"],"prefix":"10.1007","volume":"238","author":[{"given":"Dong-Hyun","family":"Youn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Mook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-ki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo-In","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Moo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1488-4110","authenticated-orcid":false,"given":"Mi Sun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,3]]},"reference":[{"key":"5840_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s002130000569","volume":"153","author":"MT Bardo","year":"2000","unstructured":"Bardo MT, Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153:31\u201343. https:\/\/doi.org\/10.1007\/s002130000569","journal-title":"Psychopharmacology"},{"key":"5840_CR2","doi-asserted-by":"publisher","first-page":"15150","DOI":"10.1523\/JNEUROSCI.3223-14.2014","volume":"34","author":"MH Baumann","year":"2014","unstructured":"Baumann MH, Solis E, Watterson LR, Marusich JA, Fantegrossi WE, Wiley JL (2014) Baths salts, spice, and related designer drugs: the science behind the headlines. J Neurosci 34:15150\u201315158. https:\/\/doi.org\/10.1523\/JNEUROSCI.3223-14.2014","journal-title":"J Neurosci"},{"key":"5840_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0165-0270(85)90071-8","volume":"13","author":"PJ Birch","year":"1985","unstructured":"Birch PJ, Fillenz M (1985) Measurement of noradrenaline synthesis in rat hippocampal synaptosomes using HPLC with ECD. J Neurosci Methods 13:231\u2013238. https:\/\/doi.org\/10.1016\/0165-0270(85)90071-8","journal-title":"J Neurosci Methods"},{"key":"5840_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00001756-199108000-00017","volume":"2","author":"JM Carney","year":"1991","unstructured":"Carney JM, Landrum RW, Cheng MS, Seale TW (1991) Establishment of chronic intravenous drug self-administration in the C57BL\/6J mouse. Neuroreport 2:477\u2013480. https:\/\/doi.org\/10.1097\/00001756-199108000-00017","journal-title":"Neuroreport"},{"key":"5840_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.bbr.2012.05.038","volume":"233","author":"JB de la Pe\u00f1a","year":"2012","unstructured":"de la Pe\u00f1a JB, Lee HC, de la Pe\u00f1a IC, Woo TS, Yoon SY, Lee HL, Han JS, Lee JI, Cho YJ, Shin CY, Cheong JH (2012) Rewarding and reinforcing effects of the NMDA receptor antagonist-benzodiazepine combination, Zoletil\u00ae: difference between acute and repeated exposure. Behav Brain Res 233:434\u2013442. https:\/\/doi.org\/10.1016\/j.bbr.2012.05.038","journal-title":"Behav Brain Res"},{"key":"5840_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0006-3223(00)01038-6","volume":"49","author":"WC Drevets","year":"2001","unstructured":"Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA, Price JL, Mathis CA (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49:81\u201396. https:\/\/doi.org\/10.1016\/s0006-3223(00)01038-6","journal-title":"Biol Psychiatry"},{"key":"5840_CR7","unstructured":"EMCDDA-Europol (2015) Annual report on the implementation of council decision 2005\/387\/JHA"},{"key":"5840_CR8","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1016\/j.cub.2017.05.084","volume":"27","author":"J Estakhr","year":"2017","unstructured":"Estakhr J, Abazari D, Frisby K, McIntosh JM, Nashmi R (2017) Differential control of dopaminergic excitability and locomotion by cholinergic inputs in mouse substantia nigra. Curr Biol 27:1900\u20131914.e4. https:\/\/doi.org\/10.1016\/j.cub.2017.05.084","journal-title":"Curr Biol"},{"key":"5840_CR9","unstructured":"European Medicines Agency (2006) Guideline on the non-clinical investigation of the dependence potential of medicinal products. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-non-clinical-investigation-dependence-potential-medicinal-products_en.pdf"},{"key":"5840_CR10","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2165\/00003495-200464140-00004","volume":"64","author":"DA Gorelick","year":"2004","unstructured":"Gorelick DA, Gardner EL, Xi Z (2004) Agents in development for the management of cocaine abuse. Drugs 64:1547\u20131573. https:\/\/doi.org\/10.2165\/00003495-200464140-00004","journal-title":"Drugs"},{"key":"5840_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nature18942","volume":"535","author":"MW Howe","year":"2016","unstructured":"Howe MW, Dombeck DA (2016) Rapid signalling in distinct dopaminergic axons during locomotion and reward. Nature 535:505\u2013510. https:\/\/doi.org\/10.1038\/nature18942","journal-title":"Nature"},{"key":"5840_CR12","unstructured":"Hunt D (1997) Pulse check: national trends in drug abuse. Diane Pub Co."},{"key":"5840_CR13","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1073\/pnas.0407737102","volume":"102","author":"KM Kahlig","year":"2005","unstructured":"Kahlig KM, Binda F, Khoshbouei H, Blakely RD, McMahon DG, Javitch JA, Galli A (2005) Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci U S A 102:3495\u20133500. https:\/\/doi.org\/10.1073\/pnas.0407737102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5840_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.mex.2014.08.002","volume":"1","author":"PK Kamat","year":"2014","unstructured":"Kamat PK, Kalani A, Tyagi N (2014) Method and validation of synaptosomal preparation for isolation of synaptic membrane proteins from rat brain. MethodsX 1:102\u2013107. https:\/\/doi.org\/10.1016\/j.mex.2014.08.002","journal-title":"MethodsX"},{"key":"5840_CR15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0091-3057(91)90005-m","volume":"38","author":"DJ McKenna","year":"1991","unstructured":"McKenna DJ, Guan XM, Shulgin AT (1991) 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine. Pharmacol Biochem Behav 38:505\u2013512. https:\/\/doi.org\/10.1016\/0091-3057(91)90005-m","journal-title":"Pharmacol Biochem Behav"},{"key":"5840_CR16","first-page":"85","volume":"2","author":"F Merz","year":"2018","unstructured":"Merz F (2018) United Nations Office on drugs and crime: world drug report 2017. SIRIUS Z Strat Anal 2:85\u201386","journal-title":"SIRIUS Z Strat Anal"},{"key":"5840_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0006-8993(82)91123-4","volume":"243","author":"RF Mucha","year":"1982","unstructured":"Mucha RF, Van Der Kooy D, O\u2019Shaughnessy M, Bucenieks P (1982) Drug reinforcement studied by the use of place conditioning in rat. Brain Res 243:91\u2013105. https:\/\/doi.org\/10.1016\/0006-8993(82)91123-4","journal-title":"Brain Res"},{"key":"5840_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/15563650.2011.647992","volume":"50","author":"DB Murray","year":"2012","unstructured":"Murray DB, Potts S, Haxton C, Jackson G, Sandilands EA, Ramsey J, Puchnarewicz M, Holt DW, Johnston A, Nicholas Bateman D, Dear JW (2012) \u2018Ivory wave\u2019 toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning. Clin Toxicol (Phila) 50:108\u2013113. https:\/\/doi.org\/10.3109\/15563650.2011.647992","journal-title":"Clin Toxicol (Phila)"},{"key":"5840_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0014-2999(76)90299-5","volume":"35","author":"A Pijnenburg","year":"1976","unstructured":"Pijnenburg A, Honig W, Van der Heyden J, Van Rossum JM (1976) Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 35:45\u201358. https:\/\/doi.org\/10.1016\/0014-2999(76)90299-5","journal-title":"Eur J Pharmacol"},{"key":"5840_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00634146","volume":"50","author":"P Protais","year":"1976","unstructured":"Protais P, Costentin J, Schwartz JC (1976) Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology 50:1\u20136. https:\/\/doi.org\/10.1007\/BF00634146","journal-title":"Psychopharmacology"},{"key":"5840_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.12.005","volume":"147","author":"ME Reith","year":"2015","unstructured":"Reith ME, Blough BE, Hong WC, Jones KT, Schmitt KC, Baumann MH, Partilla JS, Rothman RB, Katz JL (2015) Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter. Drug Alcohol Depend 147:1\u201319. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.12.005","journal-title":"Drug Alcohol Depend"},{"key":"5840_CR22","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1093\/jat\/bky101","volume":"43","author":"C Richeval","year":"2019","unstructured":"Richeval C, Nachon-Phanithavong M, Di Fazio V, Wiart J, Humbert L, Samyn N, Wille SMR, Allorge D, Gaulier J (2019) Prevalence of new psychoactive substances in oral fluid specimens from French and Belgian drivers: comparison 2016\/2017. J Anal Toxicol 43:e9\u2013e10. https:\/\/doi.org\/10.1093\/jat\/bky101","journal-title":"J Anal Toxicol"},{"key":"5840_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1124\/jpet.111.188946","volume":"341","author":"RB Rothman","year":"2012","unstructured":"Rothman RB, Partilla JS, Baumann MH, Lightfoot-Siordia C, Blough BE (2012) Studies of the biogenic amine transporters. 14. Identification of low-efficacy \u201cpartial\u201d? substrates for the biogenic amine transporters. J Pharmacol Exp Ther 341:251\u2013262. https:\/\/doi.org\/10.1124\/jpet.111.188946","journal-title":"J Pharmacol Exp Ther"},{"key":"5840_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/wps.20174","volume":"14","author":"F Schifano","year":"2015","unstructured":"Schifano F, Orsolini L, Duccio Papanti G, Corkery JM (2015) Novel psychoactive substances of interest for psychiatry. World Psychiatry 14:15\u201326. https:\/\/doi.org\/10.1002\/wps.20174","journal-title":"World Psychiatry"},{"key":"5840_CR25","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1152\/physrev.00023.2014","volume":"95","author":"W Schultz","year":"2015","unstructured":"Schultz W (2015) Neuronal reward and decision signals: from theories to data. Physiol Rev 95:853\u2013951","journal-title":"Physiol Rev"},{"key":"5840_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/15563650.2011.590812","volume":"49","author":"HA Spiller","year":"2011","unstructured":"Spiller HA, Ryan ML, Weston RG, Jansen J (2011) Clinical experience with and analytical confirmation of \u201cbath salts\u201d and \u201clegal highs\u201d (synthetic cathinones) in the United States. Clin Toxicol (Phila) 49:499\u2013505. https:\/\/doi.org\/10.3109\/15563650.2011.590812","journal-title":"Clin Toxicol (Phila)"},{"key":"5840_CR27","unstructured":"US FDA (2017) Assessment of abuse potential of drugs; guidance for industry. https:\/\/www.fda.gov\/media\/116739\/download"},{"key":"5840_CR28","unstructured":"United Nations Office on Drugs and Crime (1961) Single convention on narcotic drugs. United Nations Web. https:\/\/www.unodc.org\/unodc\/en\/treaties\/single-convention.html?ref=menuside"},{"key":"5840_CR29","unstructured":"United Nations Office on Drugs and Crime (1971) Convention on psychotropic substances. United Nations Web. https:\/\/www.unodc.org\/unodc\/en\/treaties\/psychotropics.html?ref=menuside"},{"key":"5840_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.drugpo.2016.11.007","volume":"40","author":"MC Van Hout","year":"2017","unstructured":"Van Hout MC, Hearne E (2017) New psychoactive substances (NPS) on cryptomarket fora: an exploratory study of characteristics of forum activity between NPS buyers and vendors. Int J Drug Policy 40:102\u2013110. https:\/\/doi.org\/10.1016\/j.drugpo.2016.11.007","journal-title":"Int J Drug Policy"},{"key":"5840_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/sj.mp.4001507","volume":"9","author":"ND Volkow","year":"2004","unstructured":"Volkow ND, Fowler JS, Wang G, Swanson JM (2004) Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry 9:557\u2013569. https:\/\/doi.org\/10.1038\/sj.mp.4001507","journal-title":"Mol Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05840-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-021-05840-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05840-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T03:36:06Z","timestamp":1626838566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-021-05840-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,3]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["5840"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-05840-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,3]]},"assertion":[{"value":"2 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}